An Israeli research institute has said that two medicines used to treat Gaucher’s disease could also be used to treat COVID-19, CBN News reported on May 27. Scientists at the Ministry of Defense-run Israel Institute for Biological Research (IIBR) have said Cerdelga, which has already been approved by the US Food and Drug Administration and Venglustat, which is in the process of approval, appear to inhibit viruses.
The post Israeli Research Institute says Drugs used for Gaucher’s Disease May Prove Effective Against COVID-19 appeared first on Worthy Christian News.